{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:52:01Z","timestamp":1791348721118,"version":"4.3.1"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Capsaicin (CAP) is the primary pungent alkaloid found in chili peppers. The aim of this study is to screen for candidate therapeutic agents targeting the mitochondrial dysfunction\u2013pyroptosis axis in diabetic nephropathy (DN) and to validate the efficacy and mechanism of action of capsaicin.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Bioinformatics analysis was conducted to identify candidate genes and drugs. The protective effects and underlying mechanisms of CAP were investigated using a high-glucose (HG)-induced HK-2 cell model and a streptozotocin-induced T1DM DN rat model. Experimental techniques included CCK8 assay, flow cytometry (pyroptosis and ROS), JC-1 staining, Western blot analysis, and histopathological staining. GPX4-IN-3 was applied\n                      <jats:italic>in vivo<\/jats:italic>\n                      and\n                      <jats:italic>in vitro<\/jats:italic>\n                      to determine whether it reversed the protective effects of capsaicin. The data were analyzed using the Shapiro\u2013Wilk test, one-way analysis of variance (ANOVA) with corresponding post-hoc tests, and correlation analysis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Bioinformatic analysis identified 12 intersecting genes and highlighted CAP as a potential GPX4-targeting compound. Molecular docking demonstrated a high binding affinity of CAP for GPX4 and caspase-9.\n                      <jats:italic>In vitro<\/jats:italic>\n                      , CAP dose-dependently restored cell viability and suppressed HG-induced pyroptosis in HK-2 cells. It significantly alleviated mitochondrial damage by reducing ROS production, restoring mitochondrial membrane potential, and improving mitochondrial ultrastructure. Notably, these protective effects were reversed by GPX4-IN-3. Western blot analysis revealed that CAP upregulated GPX4 expression and inhibited activation of the NLRP3\/caspase-1\/GSDMD-N pyroptosis pathway.\n                      <jats:italic>In vivo<\/jats:italic>\n                      , CAP treatment markedly improved renal histopathology and renal function in DN rats; however, these effects were attenuated by co-administration of GPX4-IN-3.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study demonstrates that CAP ameliorates diabetic renal injury by targeting GPX4, thereby mitigating mitochondrial dysfunction and subsequent NLRP3-mediated pyroptosis. These findings validate the bioinformatic prediction and reveal a novel mechanism of action for CAP, positioning it as a promising therapeutic candidate for DN.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1937280","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:47:33Z","timestamp":1791348453000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Capsaicin ameliorates diabetic nephropathy by targeted activation of GPX4 and inhibition of pyroptosis"],"prefix":"10.3389","volume":"17","author":[{"given":"Congqin","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Nephrology, The Second Hospital of Hebei Medical University","place":["Shijiazhuang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaorong","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, The Second Hospital of Hebei Medical University","place":["Shijiazhuang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The Second Hospital of Hebei Medical University","place":["Shijiazhuang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunhui","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The Second Hospital of Hebei Medical University","place":["Shijiazhuang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The Second Hospital of Hebei Medical University","place":["Shijiazhuang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinan","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The Second Hospital of Hebei Medical University","place":["Shijiazhuang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The Second Hospital of Hebei Medical University","place":["Shijiazhuang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumin","family":"Jiao","sequence":"additional","affiliation":[{"name":"Department of Nephrology, The Second Hospital of Hebei Medical University","place":["Shijiazhuang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongmei","family":"Hao","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The Second Hospital of Hebei Medical University","place":["Shijiazhuang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,10,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1617248","article-title":"Risk factors for mild cognitive impairment in type 2 diabetes: a systematic review and meta-analysis","volume":"16","author":"Zhao","year":"2025","journal-title":"Front Endocrinol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/dom.16501","article-title":"The changing epidemiology of type 1 diabetes: a global perspective","volume":"27","author":"Bell","year":"2025","journal-title":"Diabetes Obes Metab"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-025-01128-6","article-title":"Type 1 diabetes mellitus prevention: present and future","volume":"21","author":"Henriques","year":"2025","journal-title":"Nat Rev Endocrinol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.70216","article-title":"Investigation and future trend prediction of disease burden of chronic kidney disease due to diabetes mellitus type 2 globally and in China from 1990 to 2021","volume":"17","author":"Du","year":"2026","journal-title":"J Diabetes Invest"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2022.155195","article-title":"Mitochondrial dysfunction in diabetic tubulopathy","volume":"131","author":"Yao","year":"2022","journal-title":"Metab Clin Exp"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.155445","article-title":"Notoginsenoside Fc, a novel renoprotective agent, ameliorates glomerular endothelial cells pyroptosis and mitochondrial dysfunction in diabetic nephropathy through regulating HMGCS2 pathway","volume":"126","author":"Shen","year":"2024","journal-title":"Phytomedicine: Int J Phytotherapy Phytopharmacol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcb.2022.03.012","article-title":"The multifaceted role of kidney tubule mitochondrial dysfunction in kidney disease development","volume":"32","author":"Doke","year":"2022","journal-title":"Trends Cell Biol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2022.04.003","article-title":"NLRP3 and pyroptosis blockers for treating inflammatory diseases","volume":"43","author":"Coll","year":"2022","journal-title":"Trends Pharmacol Sci"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2023.2218764","article-title":"GPX4 in cell death, autophagy, and disease","volume":"19","author":"Xie","year":"2023","journal-title":"Autophagy"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13020454","article-title":"Therapeutic potential of medicinal plants and their phytoconstituents in diabetes, cancer, infections, cardiovascular diseases, inflammation and gastrointestinal disorders","volume":"13","author":"Ansari","year":"2025","journal-title":"Biomedicines"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106481","article-title":"Protective effect of berberine in diabetic nephropathy: a systematic review and meta-analysis revealing the mechanism of action","volume":"185","author":"Hu","year":"2022","journal-title":"Pharmacol Res"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/ptr.8227","article-title":"Quercetin prevented diabetic nephropathy by inhibiting renal tubular epithelial cell apoptosis via the PI3K\/AKT pathway","volume":"38","author":"Liu","year":"2024","journal-title":"Phytotherapy Research: PTR"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1093\/advances\/nmaa075","article-title":"Resveratrol: evidence for its nephroprotective effect in diabetic nephropathy","volume":"11","author":"Gowd","year":"2020","journal-title":"Adv Nutr (Bethesda Md)"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1080\/13813455.2020.1828478","article-title":"Exogenous glutamine ameliorates diabetic nephropathy in a rat model of type 2 diabetes mellitus through its antioxidant and anti-inflammatory activities","volume":"129","author":"Nasri","year":"2023","journal-title":"Arch Physiol Biochem"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.111954","article-title":"Harmine alleviated STZ-induced rat diabetic nephropathy: a potential role via regulating AMPK\/Nrf2 pathway and deactivating ataxia-telangiectasia mutated (ATM) signaling","volume":"132","author":"Tabaa","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s10565-021-09622-z","article-title":"Hirudin ameliorates diabetic nephropathy by inhibiting Gsdmd-mediated pyroptosis","volume":"39","author":"Han","year":"2023","journal-title":"Cell Biol Toxicol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13098-025-02045-4","article-title":"Honokiol attenuates diabetic nephropathy by targeting SIRT3 to suppress mitochondrial ROS-induced pyroptosis","volume":"18","author":"Yu","year":"2025","journal-title":"Diabetol Metab Syndrome"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2025.1594742","article-title":"Capsaicin: beyond TRPV1","volume":"12","author":"Ju\u00e1rez-Contreras","year":"2025","journal-title":"Front Nutr"},{"key":"B19","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s12937-024-00996-4","article-title":"Consuming spicy food and type 2 diabetes incidence in Southwestern Chinese aged 30-79: a prospective cohort study","volume":"23","author":"Chen","year":"2024","journal-title":"Nutr J"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2024.177021","article-title":"TRPV1: a novel target for the therapy of diabetes and diabetic complications","volume":"984","author":"Shen","year":"2024","journal-title":"Eur J Pharmacol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2025.1544592","article-title":"Impaired inhibitory reno-renal reflex responses in chronic kidney disease","volume":"16","author":"Rahman","year":"2025","journal-title":"Front Physiol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.156212","article-title":"Metabolic pathways, pharmacokinetic, and brain neurochemicals effects of capsaicin: comprehensively insights from in vivo studies","volume":"135","author":"Guo","year":"2024","journal-title":"Phytomedicine: Int J Phytotherapy Phytopharmacol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2019.01064","article-title":"The role of transient receptor potential vanilloid 1 in common diseases of the digestive tract and the cardiovascular and respiratory system","volume":"10","author":"Du","year":"2019","journal-title":"Front Physiol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3390\/cells10061457","article-title":"Dapagliflozin restores impaired autophagy and suppresses inflammation in high glucose-treated HK-2 cells","volume":"10","author":"Xu","year":"2021","journal-title":"Cells"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.1c00569","article-title":"Discovery of a potent glutathione peroxidase 4 inhibitor as a selective ferroptosis inducer","volume":"64","author":"Xu","year":"2021","journal-title":"J Med Chem"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1080\/0886022x.2024.2327495","article-title":"Quercetin improves diabetic kidney disease by inhibiting ferroptosis and regulating the Nrf2 in streptozotocin-induced diabetic rats","volume":"46","author":"Zhang","year":"2024","journal-title":"Renal Failure"},{"key":"B27","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.diabres.2013.01.012","article-title":"Lumbrokinase attenuates diabetic nephropathy through regulating extracellular matrix degradation in streptozotocin-induced diabetic rats","volume":"100","author":"Sun","year":"2013","journal-title":"Diabetes Res Clin Pract"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.13120","article-title":"Capsaicin alleviates cisplatin-induced muscle loss and atrophy in vitro and in vivo","volume":"14","author":"Huang","year":"2023","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2008.01.011","article-title":"Increased GFR and renal excretory function by activation of TRPV1 in the isolated perfused kidney","volume":"57","author":"Li","year":"2008","journal-title":"Pharmacol Res"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2020.154182","article-title":"Activation of TRPV1 channel antagonizes diabetic nephropathy through inhibiting endoplasmic reticulum-mitochondria contact in podocytes","volume":"105","author":"Wei","year":"2020","journal-title":"Metab Clin Exp"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.104258","article-title":"Single cell RNA-seq analysis identifies ferroptotic chondrocyte cluster and reveals TRPV1 as an anti-ferroptotic target in osteoarthritis","volume":"84","author":"Lv","year":"2022","journal-title":"EBioMedicine"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1002\/smtd.202301271","article-title":"Stimulus-responsive nano-prodrug strategies for cancer therapy: a focus on camptothecin delivery","volume":"8","author":"Chu","year":"2024","journal-title":"Small Methods"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.2174\/1874467215666211217122523","article-title":"Therapeutic potential of resveratrol in diabetic nephropathy according to molecular signaling","volume":"15","author":"Salami","year":"2022","journal-title":"Curr Mol Pharmacol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3390\/biom12091227","article-title":"Oxidative stress and NRF2\/KEAP1\/ARE pathway in diabetic kidney disease (DKD): new perspectives","volume":"12","author":"Tanase","year":"2022","journal-title":"Biomolecules"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-022-00729-9","article-title":"Cytosolic escape of mitochondrial DNA triggers cGAS-STING-NLRP3 axis-dependent nucleus pulposus cell pyroptosis","volume":"54","author":"Zhang","year":"2022","journal-title":"Exp Mol Med"},{"key":"B36","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1186\/s12967-023-04187-3","article-title":"IL-17A-mediated mitochondrial dysfunction induces pyroptosis in colorectal cancer cells and promotes CD8\u2009+\u2009T-cell tumour infiltration","volume":"21","author":"Feng","year":"2023","journal-title":"J Transl Med"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116512","article-title":"GPX4, ferroptosis, and diseases","volume":"174","author":"Zhang","year":"2024","journal-title":"Biomedicine Pharmacother = Biomedecine Pharmacotherapie"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-025-05042-w","article-title":"GPX4 inhibition contributes to NLRP3-mediated pyroptosis and cognitive impairment in ketamine-exposed neonatal rats","volume":"62","author":"Bai","year":"2025","journal-title":"Mol Neurobiol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnutbio.2022.109001","article-title":"MiR-1656 targets GPX4 to trigger pyroptosis in broilers kidney tissues by activating NLRP3 inflammasome under Se deficiency","volume":"105","author":"Gu","year":"2022","journal-title":"J Nutr Biochem"},{"key":"B40","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s00395-022-00948-1","article-title":"Mitochondrial calpain-1 activates NLRP3 inflammasome by cleaving ATP5A1 and inducing mitochondrial ROS in CVB3-induced myocarditis","volume":"117","author":"Liu","year":"2022","journal-title":"Basic Res Cardiol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2021.102010","article-title":"Quercetin hinders microglial activation to alleviate neurotoxicity via the interplay between NLRP3 inflammasome and mitophagy","volume":"44","author":"Han","year":"2021","journal-title":"Redox Biol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3109\/01913123.2013.830166","article-title":"Effects of thymoquinone on STZ-induced diabetic nephropathy: an immunohistochemical study","volume":"38","author":"Omran","year":"2014","journal-title":"Ultrastructural Pathol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.26402\/jpp.2023.3.06","article-title":"Isosteviol attenuates streptozotocin-mediated diabetic nephropathy in rats by upregulating and stimulating adenosine monophosphate-activated protein kinase","volume":"74","author":"Altamimi","year":"2023","journal-title":"J Physiol Pharmacol: Off J Polish Physiol Soc"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1937280\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:47:41Z","timestamp":1791348461000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1937280\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,7]]},"references-count":43,"alternative-id":["10.3389\/fendo.2026.1937280"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1937280","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,7]]},"article-number":"1937280"}}